[Treatment Options for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): With a Focus on Immunoglobulin Treatment].

Abstract

The disease state and clinical course of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are diverse, and the response to treatment varies from patient to patient. Therefore, it is necessary to select a treatment and determine the appropriate dose and dosage interval while monitoring the clinical course after treatment initiation. In this article, we will discuss points to be considered and the results of studies that can be used as references in order to make an appropriate choice at each stage of CIDP treatment.

• Authors: Michiaki Koga, Masahiro Iijima, Taku Fukushima, Kenichi Kaida
• Journal: Brain and nerve = Shinkei kenkyu no shinpo (Brain Nerve) Vol. 73 Issue 11 Pg. 1275-1284 (Nov 2021) ISSN: 1881-6096 [Print] Japan
• PMID: 34759066 (Publication Type: Journal Article)

Chemical References

• Immunoglobulins

Topics

• Humans
• Immunoglobulins
• Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (diagnosis, drug therapy)